Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03110003 · ClinicalTrials.gov registry record · Phase 3
Bupivacaine With Epidural Volume Extension
A Phase 3 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
NCT03110003 is a Phase 3 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants.
The verdict
NCT03110003, a Phase 3 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
Study Summary
In this study the investigator will address the efficacy of using low dose bupivacaine spinal anesthesia (SA) in combination with epidural volume extension (EVE) for patients undergoing short obstetric procedures.
Interventions
- DRUG 10 mg Bupivacaine
- DRUG 5 mg Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-06-27 |
| Est. Completion | 2018-09-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03110003
The ClinicalTrials.gov registry entry for NCT03110003 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 10 mg Bupivacaine is the first listed.
NCT03110003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03110003 about?
NCT03110003 is a clinical study titled "Bupivacaine With Epidural Volume Extension". In this study the investigator will address the efficacy of using low dose bupivacaine spinal anesthesia (SA) in combination with epidural volume extension (EVE) for patients undergoing short obstetric procedures.
What is the current status of trial NCT03110003?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2016-06-27. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT03110003?
The interventions under investigation include: 10 mg Bupivacaine (DRUG), 5 mg Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03110003?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.